NFKB1 and Parkinson disease: In addition, inhibition of MAPK and NFκB signaling pathways was found to play a neuroprotective role in central nervous system (CNS) diseases such as PD and epilepsy (Mattson and Camandola, 2001; Singh and Singh, 2020; Yu et al., 2021).